Coloplast buys up fish skin wound care biotech Kerecis for $1.3B
The acquisition will give Coloplast the opportunity to expand into the growing advanced wound care market.
Source: mmm-online.com
Stay updated with breaking news from Evaluate Vantage. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The acquisition will give Coloplast the opportunity to expand into the growing advanced wound care market.
Pharmaceutical Company Sets Gold Standard for New Drugs
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Pharmaceutical stocks overall have fared well during this tough year for the ma...
(RTTNews) - The FDA approved three novel drugs in March, bringing the total number of novel drug approvals this year to ten. Now, let's take a lo...